Avanza Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.03 Cr
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
About Avanza Life Sciences
Avanza Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 July 2014 and has a history of Ten years and seven months. Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Raju Paul, Cheruvalappil Akbar, Puthan Ajayakumar, and Four other members serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909KL2014PTC036856
- Company No.
036856
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Avanza Life Sciences?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raju Paul  | Director | 09-Jul-2014 | Current |
| Cheruvalappil Akbar | Director | 09-Jul-2014 | Current |
| Puthan Ajayakumar | Director | 01-May-2017 | Current |
| Tarson Francis | Director | 01-May-2017 | Current |
| Vadakumbadan Bhaskaran | Director | 05-May-2017 | Current |
| Azghar Ashraf | Additional Director | 24-Aug-2020 | Current |
Financial Performance of Avanza Life Sciences.
Avanza Life Sciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Avanza Life Sciences?
In 2017, Avanza Life Sciences had a promoter holding of 82.67% and a public holding of 17.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Perfident Healthcare Private LimitedRaju Paul is a mutual person
- Perfimed Services Private Limited
Raju Paul, Cheruvalappil Akbar and 2 more are mutual person
- Nbd Healthcare Private Limited
Cheruvalappil Akbar is a mutual person
- Rasheenas Herbal Products Llp
Mohamed Anwar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avanza Life Sciences?
Unlock and access historical data on people associated with Avanza Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avanza Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avanza Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
